Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$118.49

0.93 (0.79%)

, UNH

UnitedHealth

$134.13

0.21 (0.16%)

20:25
10/17/16
10/17
20:25
10/17/16
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.65... UnitedHealth Group (UNH), consensus $2.08... Goldman Sachs (GS), consensus $3.79... BlackRock (BLK), consensus $4.98... Omnicom (OMC), consensus $1.03... W.W. Grainger (GWW), consensus $2.99... Regions Financial (RF), consensus 21c... Kansas City (KSU), consensus $1.22... Harley-Davidson (HOG), consensus 64c... Comerica (CMA), consensus 74c... Domino's Pizza (DPZ), consensus 89c... Synovus (SNV), consensus 50c... Tile Shop (TTS), consensus 8c.

JNJ

Johnson & Johnson

$118.49

0.93 (0.79%)

UNH

UnitedHealth

$134.13

0.21 (0.16%)

GS

Goldman Sachs

$169.00

-1.52 (-0.89%)

BLK

BlackRock

$354.60

-0.31 (-0.09%)

OMC

Omnicom

$82.83

-0.04 (-0.05%)

GWW

Grainger

$214.58

0.37 (0.17%)

RF

Regions Financial

$10.01

-0.04 (-0.40%)

KSU

Kansas City Southern

$94.71

0.16 (0.17%)

HOG

Harley-Davidson

$49.70

-0.13 (-0.26%)

CMA

Comerica

$48.06

-0.34 (-0.70%)

DPZ

Domino's Pizza

$152.01

0.89 (0.59%)

SNV

Synovus

$31.99

-0.03 (-0.09%)

TTS

Tile Shop

$16.75

0.1 (0.60%)

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 21

    Oct

  • 21

    Oct

  • 01

    Nov

  • 04

    Nov

  • 06

    Nov

  • 10

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 17

    Nov

  • 17

    Nov

  • 18

    Nov

JNJ Johnson & Johnson
$118.49

0.93 (0.79%)

10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Johnson & Johnson weakness creates buying opportunity, says RBC Capital
RBC Capital analyst Glenn Novarro says that Johnson & Johnson underperformed the market in Q3 due to a number of factors including Remicade biosimilar risk and the pharma pricing debate. The analyst says that "these concerns are manageable/overblown," and he expects the company to report strong Q3 results, driven by a strong pharma performance. Novoroo expects the company's Q3 revenue to come in slightly above expectations, and he predicts that the company will narrow its 2016 EPS guidance to the high end of the previous range. The analyst recommends buying the stock. He keeps a $133 price target and Outperform rating on the shares.
09/19/16
LEER
09/19/16
NO CHANGE
LEER
Abbott, Johnson & Johnson transaction positive for both companies, says Leerink
Leerink analyst Danielle Antalffy says the sale of Abbott's (ABT) Medical Optics ophthalmology business to Johnson & Johnson (JNJ) is positive for both companies. The deal strengthens Abbott's balance sheet and eliminates the need for a previously expected $3B capital raise, and adds a key component to Johnson & Johnson's already-strong vision care franchise, the analyst notes.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
08/24/16
JEFF
08/24/16
NO CHANGE
Target $210
JEFF
Buy
Cooper Companies estimates raised at Jefferies after doctor survey
Jefferies analyst Anthony Petrone reports that the firm's survey of 52 new optometry practices suggest continued gains in dailies and stable share in monthlies for Cooper Companies (COO) and that Johnson & Johnson's (JNJ) Acuvue Vita is off to slow start. Based on the survey results, and a "significant" foreign exchange tailwind, Petrone raised his estimates for Cooper and increased his price target on the shares to $210 from $190. The firm has a Buy rating on Cooper shares.
UNH UnitedHealth
$134.13

0.21 (0.16%)

09/14/16
ADAM
09/14/16
NO CHANGE
Target $155
ADAM
Buy
LabCorp weakness a buying opportunity, says Canaccord
Canaccord analyst Mark Massaro noted LabCorp (LH) shares sold off yesterday on news that its rival, Quest Diagnostics (DGX), announced a partnership with Optum, a subsidiary of UnitedHealth (UNH). The analyst said LabCorp does not believe Quest can wrestle away UnitedHealth's long-standing lab services contract when it goes up for renewal in 2018. Massaro expects LabCorp to deliver steady quarterly beats and said the company is well positioned to capture its losses in the second half of 2016. Massaro reiterated his Buy rating and $155 price target on LabCorp shares.
09/13/16
CHLM
09/13/16
NO CHANGE
CHLM
LabCorp impact from Quest-Optum collaboration limited, says Craig-Hallum
Craig-Hallum analyst Bill Bonello said the Quest Diagnostics (DGX) and Optum, a division of United Healthcare (UNH), collaboration does not put LabCorp's (LH) revenue at risk. The collaboration does not create any lab benefit management service, or a preferred lab network with Quest at the hub, that would drive business to Quest labs or compete with Labcorp's Beacon LBS lab management business, the analyst wrote. Bonellow said UnitedHealthcare and LabCorp continue to work together to expand the Beacon LBS model to other markets and we would expect to see the Beacon lab network expand to other payors overtime. Also, the analyst said the collaboration does not impact LabCorp's contract with UnitedHealthcare, or UHC, and and has no impact on that contract today and does not imply a change to UHC's contracting strategy going forward. Bonello rates LabCorp a Buy with a $160 price target.
09/22/16
PIPR
09/22/16
NO CHANGE
Target $155
PIPR
Overweight
UnitedHealth won VA contract worth $1B per year, says Piper Jaffray
Piper Jaffray analyst Sean Wieland says UnitedHealth unit Optum has won a contract with the U.S. Department of Veterans Affairs to provide medical disability examinations. The analyst estimates the contract, awarded to Optum wholly owned subsidiaries Logistics Health and Medical Support Los Angeles, represents $1B per year. Wieland estimates the award will be neutral to earnings in year one and become accretive in 2018. He reiterates an Overweight rating on UnitedHealth shares with a $155 price target.
09/22/16
EVER
09/22/16
INITIATION
Target $155
EVER
Buy
UnitedHealth initiated with a Buy at Evercore ISI
Evercore ISI initiated UnitedHealth with a Buy and a $155 price target.
GS Goldman Sachs
$169.00

-1.52 (-0.89%)

07/13/16
BREN
07/13/16
INITIATION
Target $140
BREN
Hold
Goldman Sachs initiated with a Hold at Berenberg
Target $140.
07/13/16
07/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Citi (C) initiated with a Buy, JPMorgan (JPM) initiated with a Sell, Goldman Sachs (GS) and Morgan Stanley (MS) initiated with a Hold at Berenberg. 2. Ingersoll-Rand (IR) initiated with an Outperform at BMO Capital. 3. Incyte (INCY) initiated with an Outperform at RBC Capital. 4. Williams (WMB) reinstated with a Buy at Goldman. 5. E-Trade (ETFC) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Oppenheimer technical analyst upgrades Financials, downgrades Consumer Staples
Oppenheimer technical analyst Ari Wald upgraded the Financials sector to Market Weight and downgraded Consumer Staples to Underweight in next step in the firm's "cyclical rotation road map." Wald identified Ameriprise (AMP), Bank of America (BAC), Citi (C), Goldman Sachs (GS), Lincoln National (LNC) and SunTrust (STI) as six stocks breaking higher that he sees as likely to benefit from internal market rotation.
10/17/16
RAFF
10/17/16
UPGRADE
RAFF
Buy
Goldman Sachs upgraded to Buy from Hold at Rafferty Capital
BLK BlackRock
$354.60

-0.31 (-0.09%)

10/14/16
DBAB
10/14/16
DOWNGRADE
Target $32
DBAB
Hold
Invesco downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded Invesco (IVZ) to Hold saying implementation of the Department of Labor rule in Q4 and Q1 will drive accelerating outflows in active mutual fund products. The analyst lowered his price target for the shares to $32 from $36. Bedell now favors BlackRock (BLK) in the Asset Managers space although he did lower his price target for the name to $416 from $418.
08/08/16
GSCO
08/08/16
DOWNGRADE
GSCO
Buy
BlackRock downgraded to Buy from Conviction Buy at Goldman
Goldman analyst Alexander Blostein removed BlackRock from the Conviction Buy List given expectations for a deceleration in near-term organic fee rate growth, which will limit multiple expansion. The analyst maintains his Buy rating and $400 price target saying BlackRock will deliver industry leading organic growth, but a more difficult mix shift could pressure the firm's overall fee rate/organic revenue growth.
07/15/16
KBWI
07/15/16
DOWNGRADE
Target $383
KBWI
Market Perform
BlackRock downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee downgraded BlackRock to Market Perform saying the company's "strong organic growth prospects" are largely priced into the shares at current levels. The analyst lowered his price target for the shares to $383 from $390 following BlackRock's Q2 results.
06/02/16
UBSW
06/02/16
UPGRADE
UBSW
Buy
Envestnet upgraded to Buy from Neutral at UBS
UBS analyst Brennan Hawken upgraded Envestnet to Buy saying the company is one of the few beneficiaries of the Department of Labor's fiduciary rule. Hawken this morning also downgraded Franklin Resources (BEN) to Sell and Invesco (IVZ) to Neutral. He also lowered his estimates for BlackRock (BLK) and T. Rowe Price (TROW).
OMC Omnicom
$82.83

-0.04 (-0.05%)

04/14/16
04/14/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cowen analyst Charles Neivert downgraded Potash (POT), Mosaic (MOS), Intrepid Potash (IPI) and CF Industries (CF), all to Underperform, citing the risk of further deterioration in the grain environment. He also cites the belief that nutrient prices and margins still have room to fail. Neivert said an increase in U.S. corn acreage to 93.6M acres, combined with likely gains in Brazilian and Argentine output, would likely result in a very sizable drop in both corn price and 2017 acreage. 2. PepsiCo (PEP) downgraded to Hold at Stifel citing valuation and its belief that the stock probably lacks "structural or growth-related catalysts." 3. Lennox (LII) downgraded to Sector Weight at KeyBanc with analyst Jeffrey Hammond saying he expects the stock to trade more in line with the peers after a period of multiple expansion. 4. Omnicom (OMC) downgraded to Market Perform at Wells Fargo by analyst Peter Stabler, who said expectations for margin expansion are priced into the shares at current levels. 5. Graco (GGG) downgraded to Neutral at SunTrust citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/14/16
WELS
04/14/16
DOWNGRADE
WELS
Market Perform
Omnicom downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Peter Stabler downgraded Omnicom (OMC) to Market Perform saying expectations for margin expansion are priced into the shares at current levels. The analyst raised his price target range for the stock to $82-$84 from $80-$82. The analyst coupled the downgrade with an upgrade of MDC Partners (MDCA).
10/06/16
RBCM
10/06/16
INITIATION
Target $87
RBCM
Sector Perform
Omnicom initiated with a Sector Perform at RBC Capital
RBC Capital analyst Steven Cahill initiated Omnicom with a Sector Perform and an $87 price target.
09/15/16
FBCO
09/15/16
INITIATION
Target $83
FBCO
Neutral
Omnicom initiated with a Neutral at Credit Suisse
Credit Suisse analyst Omar Sheikh initiated Interpublic Group with a Neutral and a $83 price target on shares.
GWW Grainger
$214.58

0.37 (0.17%)

06/17/16
FBCO
06/17/16
DOWNGRADE
FBCO
Neutral
Grainger downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Andrew Buscaglia assumed coverage on Grainger with a Neutral rating from an Outperform rating citing margin pressures and weak pricing in the U.S. Buscaglia has a $222 price target on Grainger shares.
09/08/16
GSCO
09/08/16
NO CHANGE
GSCO
Goldman's Focus List changes
Goldman added Acuity Brands (AYI) & Facebook (FB) to the Focus List and removed Biogen (BIIB), BorgWarner (BWA), Monsanto (MON), and Grainger (GWW). The bank commented Acuity is a beneficiary of the Low Carbon Economy and said Facebook ranks as a low asset-light tech disruptor that is able to leverage its world-leading user base and mobile users to monetize long-term growth.
08/25/16
MACQ
08/25/16
INITIATION
Target $274
MACQ
Outperform
Grainger initiated with an Outperform at Macquarie
Macquarie analyst Hamzah Mazari initiated Grainger with an Outperform and $274 price target.
06/17/16
06/17/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Phillips 66 (PSX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Evan Calo citing relative share outperformance year-to-date. 2. Grainger (GWW) downgraded to Neutral from Outperform at Credit Suisse with analyst Andrew Buscaglia citing margin pressures and weak pricing in the U.S. 3. Talen Energy (TLN) downgraded to Equal Weight from Overweight at Barclays with analyst Daniel Ford citing valuation, among other reasons. 4. MSC Industrial (MSM) downgraded to Underperform from Neutral at Credit Suisse with analyst Andrew Buscaglia saying stabilizing trends are largely priced in. 5. ONEOK (OKE) downgraded to Hold from Buy at Argus with analyst Stephen Bigger citing the strong run-up in shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RF Regions Financial
$10.01

-0.04 (-0.40%)

10/06/16
WEDB
10/06/16
INITIATION
Target $12
WEDB
Outperform
Regions Financial initiated with an Outperform at Wedbush
Wedbush analyst Peter Winter initiated Regions Finacial with an Outperform and a $12 price target.
10/06/16
WEDB
10/06/16
INITIATION
WEDB
Outperform
Citizens Financial initiated with an Outperform at Wedbush
Wedbush analyst Peter Winter initiated coverage of 14 regional and Texas banks, starting Citizens Financial (CFG) with an Outperform rating. The other three banks on which Winter assigned an Outperform rating are KeyCorp (KEY), Huntington Bancshares (HBAN) and Regions Financial (RF).
10/06/16
RAJA
10/06/16
DOWNGRADE
RAJA
Outperform
Regions Financial downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst David Long downgraded Regions Financial to Outperform due to strong share performance and maintained its $10.50 price target.
10/11/16
FBRC
10/11/16
DOWNGRADE
Target $10.5
FBRC
Market Perform
Regions Financial downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Steve Moss downgraded Regions Financial to Market Perform after assuming coverage of the name from Paul Miller. He has a $10.50 price target for the shares. The analyst cites slower loan growth for his more conservative revenue outlook relative to consensus.
KSU Kansas City Southern
$94.71

0.16 (0.17%)

10/11/16
BOFA
10/11/16
NO CHANGE
Target $110
BOFA
Buy
Kansas City Southern added to US 1 List at BofA/Merrill
BofA/Merrill analyst Ken Hoexter added Kansas City Southern to the US 1 List saying the company is positioned to achievable sizable operating improvements and above peer group volume growth in 2017 and beyond. The analyst expects Kansas City to benefit from long-term growth opportunities from five new auto plants on its network in Mexico, the second opening at Port of Lazaro Cardenas, and other long-term opportunities such as Sasol's cracker, ,expected to be operational in 2018/19. Hoexter raised Kansas City's price target to $110 from $107 on shares.
09/29/16
LOOP
09/29/16
NO CHANGE
Target $115
LOOP
Buy
Loop Capital wonders if Trump is trying to kill Kansas City Southern
Following Monday's presidential debate, Loop Capital analyst Rick Paterson is rethinking his reluctance to believing a potential Donald Trump presidency is a threat to Kansas City Southern's business. Trump opened the debate by attacking Kansas City Southern customer Ford Motor's (F) transplanting of auto assembly plants from the U.S. to Mexico, Paterson tells investors in a research note. KSU was the best performing rail stock and the Mexican peso was 2.5% stronger the day after Hillary Clinton's debate victory, the analyst points out. He views Mexico as a "key growth engine" for both KSU and Union Pacific (UNP). Paterson cites a CNN poll for Clinton's debate victory. The analyst has a Buy rating on KSU with a $115 price target.
10/11/16
VERT
10/11/16
INITIATION
VERT
Hold
Kansas City Southern initiated with a Hold at Vertical Research
09/13/16
SBSH
09/13/16
NO CHANGE
Target $170
SBSH
Buy
Rails remain attractive into year-end, says Citi
Citi analyst Christian Wetherbee says he continues to view railroads as the most attractive sector within Transportation into year-end and early 2017. Rail volumes could flatten and begin to turn modestly positive by the end of 2016, which would likely extend investor rotation into the space, Wetherbee tells investors in a research note. He believes valuations in the rails sector remain attractive and that 2017 estimates are achievable. Wetherbee raised his price target for Canadian Pacific (CP) to $170 from $154, for Canadian National (CNI) to $66 from $61, for CSX (CSX) to $32 from $29, for Kansas City Southern (KSU) to $110 from $109, for Norfolk Southern (NSC) to $97 from $87 and for Union Pacific (UNP) to $106 from $100. He has Buy ratings on Canadian Pacific, CSX, Kansas City Southern and Union Pacific.
HOG Harley-Davidson
$49.70

-0.13 (-0.26%)

09/30/16
09/30/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with a Buy at Guggenheim. 2. Wal-Mart (WMT) initiated with an Overweight at KeyBanc and a Buy at Guggenheim. 3. Harley-Davidson (HOG) initiated with a Hold at Jefferies. 4. Coach (COH) was initiated with a Buy at Guggenheim while the firm initiated Michael Kors (KORS) with a Neutral. 5. First Solar (FSLR) initiated with a Buy at Williams Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/15/16
UBSW
09/15/16
NO CHANGE
Target $54
UBSW
Neutral
UBS sees downside risk to Harley-Davidson guidance
UBS analyst Robin Farley analyzed 25 years of inventory data for Harley-Davidson and concluded there are downside risks to the company's guidance. The analyst said the math suggests retail sales would have to grow at a mid-single digit rate and the company's second half expectations for shipments seem high. Farley maintained her Neutral rating and lowered her price target to $54 from $55 on Harley-Davidson shares.
09/16/16
WEDB
09/16/16
NO CHANGE
Target $48
WEDB
Neutral
Harley-Davidson used bike pricing getting worse, says Wedbush
Wedbush analyst James Hardiman said the firm's Harley-Davidson used bike pricing study found that used model-year 2015 bikes are selling, on average, at the largest discount seen since 2006 and that nearly all model years are seeing trade-in prices relative to their initial MSRPs that are at or near the recessionary levels of 2008-2009. The survey results are a negative both for Harley-Davidson Financial Services and for new bike demand, said Hardiman, who keeps a Neutral rating on Harley shares.
09/30/16
JEFF
09/30/16
INITIATION
Target $49
JEFF
Hold
Harley-Davidson initiated with a Hold at Jefferies
Jefferies analyst Trevor Young started Harley-Davidson (HOG) with a Hold rating and $49 price target. The analyst is concerned about peaking U.S. motorcycle demand and Harley's rising mix of financing. Young this morning named Fox Factory (FOXF) his top pick in Powersports.
CMA Comerica
$48.06

-0.34 (-0.70%)

09/16/16
09/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) coverage assumed with an Outperform from Neutral at Credit Suisse with analyst Edward Kelly saying he is encouraged by Wal-Mart's return to traffic growth against a deteriorating staples retail environment and its aggressive U.S. investments to solidify its position in an evolving industry. 2. Clorox (CLX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Comerica (CMA) upgraded to Conviction Buy from Neutral at Goldman with analyst Ryan Nash saying he sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. 4. Hormel Foods (HRL) upgraded to Buy from Hold at Edward Jones. 5. Micron (MU) upgraded to Buy from Neutral at Cleveland Research with analyst Kevin Rottinghaus saying Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
WEDB
10/06/16
INITIATION
Target $29
WEDB
Neutral
Comerica initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated Comerica with a Neutral and a $29 price target.
10/11/16
10/11/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Comerica (CMA) downgraded to Market Perform from Outperform at FBR Capital with analyst Bob Ramsey citing valuation following the recent strength in the shares. 2. Charter downgraded to Neutral from Buy at MoffettNathanson with analyst Craig Moffett saying shares have risen sharply year-to-date, along with consensus estimates, and views shares as fairly valued. 3. BHP Billiton (BHP) downgraded to Neutral from Buy at UBS with the firm citing its expectations for lower iron ore and coal prices over the next six months. 4. Illumina (ILMN) downgraded to Sell from Neutral at Janney Capital and to Neutral from Buy at Citi. 5. KBR (KBR) downgraded to Sell from Neutral at Goldman with analyst Jerry Revich citing limited growth prospects due to outsized exposure to core LNG and greenfield ammonia capex cycles that are in the early stages of decline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/16
FBRC
10/11/16
DOWNGRADE
Target $50
FBRC
Market Perform
Comerica downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Bob Ramsey downgraded Comerica to Market Perform citing valuation following the recent strength in the shares. The analyst keeps a $50 price target for the stock.
DPZ Domino's Pizza
$152.01

0.89 (0.59%)

07/05/16
LBOW
07/05/16
NO CHANGE
Target $145
LBOW
Buy
Domino's Pizza Q2 comps above consensus, says Longbow
Longbow analyst Alton Stump's checks indicate Domino's Pizza's domestic franchised same-store-sales were up in a 7%-7.5% range in Q2, in line with his 7.3% franchised comp growth estimate but ahead of consensus of 6.2%. Stump reiterates his Buy rating and $145 price target on Domino's shares.
10/14/16
BOFA
10/14/16
UPGRADE
BOFA
Buy
Domino's Pizza upgraded to Buy from Underperform at BofA/Merrill
10/14/16
10/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConAgra (CAG) upgraded to Outperform from Sector Perform at RBC Capital with analyst David Palmer citing valuation. 2. Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray after the firm's semi-annual proprietary "Taking Stock With Teens" survey. 3. Domino's Pizza (DPZ) upgraded to Buy from Underperform at BofA/Merrill with analyst Gregory Francfort saying he believes Domino's has further growth ahead and will take share in the fragmented $34B U.S. pizza category. 4. TSMC (TSM) upgraded to Sector Weight from Underweight at Pacific Crest with analyst Michael McConnell citing a more favorable margin outlook and share gains at the 10 nm node. 5. Level 3 (LVLT) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying expectations have been lowered along with the share price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/14/16
10/14/16
UPGRADE
Target $175

Buy
Domino's Pizza upgraded two notches on growth opportunity at BofA/Merrill
As previously reported, BofA/Merrill upgraded Domino's Pizza two notches to Buy from Underperform and raised its price target to $175 from $120. Analyst Gregory Francfort believes Domino's has further growth ahead and will take share in the fragmented $34B US pizza category. The analyst expects 7.3% domestic system sales growth over the next six years and said shares discount 6.7% growth. He expects Domino's sales growth to continue driven by modest growth in the quick service pizza category, general market share gains by large chains due to digital ordering advantages, remodeling and relocation upgrades, digital customer data lead following its loyalty rollout, and impressive management.
SNV Synovus
$31.99

-0.03 (-0.09%)

06/29/16
BOFA
06/29/16
DOWNGRADE
Target $30
BOFA
Neutral
Synovus downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded Synovus to Neutral and lowered its price target to $30 based on a slowing growth outlook, challenges on improving ROA in a low rate environment, and lack of larger bank M&A activity.
04/20/16
04/20/16
DOWNGRADE

Market Perform
Synovus downgraded to Market Perform on valuation at Raymond James
As previously reported, Raymond James downgraded Synovus to Market Perform from Outperform. Analyst Michael Rose said Q1 results were modestly below consensus and downgraded shares citing balanced risk/reward.
06/29/16
06/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on the today's top five analyst downgrades with this list compiled by The Fly: 1. HeartWare (HTWR) downgraded to Equal Weight from Overweight at Barclays by analyst Matthew Taylor, saying he does not expect a competing takeover bid to Medtronic's (MDT) offer. The analyst raised his price target for the shares to $58 from $35. Similarly, shares were downgraded to Market Perform from Outperform at Wells Fargo, with analyst Larry Biegelsen saying he sees a low likelihood that a higher bidder will emerge. The analyst believes Medtronic paid a fair valuation for HeartWare. HeartWare was also downgraded to Neutral from Buy at BTIG. 2. Esperion (ESPR) downgraded to Neutral from Overweight at JPMorgan by analyst Jessica Fye, who slashed her price target for shares to $15 from $50. The analyst says last night's regulatory update is a net negative. Disappointingly, the FDA did not sign off on the use of LDL-C lowering as an acceptable regulatory endpoint for approval of bempedoic acid for the treatment of statin-intolerant patients, Fye tells investors in a research note. The analyst still believes bempedoic acid is an effective LDL-C lowering agent, but now sees a drawn out path to approval in the U.S. Esperion was also downgraded to Underperform at Neutral at Credit Suisse by analyst Vamil Divan, who says the update on the development plans for bempedoic acid leaves him increasingly concerned about the products outlook in the U.S. market. The analyst was surprised that the FDA may not be willing to allow LDL-C as a surrogate endpoint for initial approval but believes there will be significant pressure, and limited upside, on shares until that certainty is obtained, and that process may take years to play out. Esperion was also downgraded to Sector Perform from Outperform at RBC Capital. 3. Comerica (CMA) downgraded to Underperform from Neutral at BofA/Merrill, which reduced its price target to $36 from $45. The firm's analyst lowered estimates 8% below consensus for 2016 and 17% below consensus in 2017 due to low rates that will pressure spread revenue growth, slower U.S. economic growth, and continued reserve build. The firm also downgraded Regions Financial (RF), Synovus (SNV), Texas Capital (TCBI) and Franklin Financial Network (FSB) to Neutral from Buy, as well as Zions Bancorp (ZION) to Underperform from Neutral. 4. comScore (SCOR) downgraded to Neutral from Positive at Susquehanna, citing uncertainty surrounding its accounting issues. The firm continues to like the long-term fundamental story, but with an unclear timeline for its resolution, they are moving to the sidelines. Susquehanna lowered its price target to $18 from $30 on comScore shares. 5. Harman (HAR) downgraded to Sector Perform from Outperform at RBC Capital partly based on the low number of new car launches next year, the firm's forecast for reduced production by the company's European customers, and the firm's reduction in its U.S. auto production versus its previous forecast. Additionally, the firm expects GM (GM) to delay a number of its connected car launches that had been slated for fiscal 2017 until fiscal 2018. The firm lowered its price target to $73 from $85. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/16
WELS
08/23/16
DOWNGRADE
WELS
Underperform
Synovus downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Jared Shaw downgraded Synovus to Underperform citing premium valuation with below peer profitability.
TTS Tile Shop
$16.75

0.1 (0.60%)

04/06/16
NORL
04/06/16
INITIATION
Target $19.5
NORL
Outperform
Tile Shop initiated with an Outperform at Northland
Northland analyst Reed Anderson started Tile Shop Holdings with an Outperform rating and $19.50 price target. Store productivity and steady growth over the next several years should drive "meaningful" share appreciation, Anderson tells investors in a research note.
12/21/15
PIPR
12/21/15
NO CHANGE
Target $20
PIPR
Overweight
Tile Shop fundamentals remain strong, says Piper Jaffray
After meeting with management, Piper Jaffray analyst Peter Keith says Tile Shop's business fundamentals remain strong for Q4 and heading into 2016. He raised his price target for shares to $20 from $18 ad reiterates an Overweight rating on the name.

TODAY'S FREE FLY STORIES

MTN

Vail Resorts

$160.92

-1.81 (-1.11%)

20:25
12/08/16
12/08
20:25
12/08/16
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

MON

Monsanto

$104.70

-0.71 (-0.67%)

20:17
12/08/16
12/08
20:17
12/08/16
20:17
Hot Stocks
Washington sues Monsanto over PCB contamination »

Washington Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 27

    Jan

USAC

USA Compression

$18.01

-0.14 (-0.77%)

20:15
12/08/16
12/08
20:15
12/08/16
20:15
Syndicate
USA Compression 4.5M share Spot Secondary priced at $16.25 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ICHR

Ichor Holdings

20:11
12/08/16
12/08
20:11
12/08/16
20:11
Syndicate
Ichor Holdings 5.9M share IPO priced at $9.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GOOG

Alphabet

$776.42

5.23 (0.68%)

, GOOGL

Alphabet Class A

$795.17

3.7 (0.47%)

19:53
12/08/16
12/08
19:53
12/08/16
19:53
Periodicals
YouTube-NMPA settlement estimated at over $40M, NY Times says »

The agreement between…

GOOG

Alphabet

$776.42

5.23 (0.68%)

GOOGL

Alphabet Class A

$795.17

3.7 (0.47%)

SNE

Sony

$29.16

0.55 (1.92%)

VIVHY

Vivendi

$18.83

-0.455 (-2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

GOOG

Alphabet

$776.42

5.23 (0.68%)

, GOOGL

Alphabet Class A

$795.17

3.7 (0.47%)

19:46
12/08/16
12/08
19:46
12/08/16
19:46
Hot Stocks
YouTube reaches agreement to pay out unclaimed song royalties »

The National Music…

GOOG

Alphabet

$776.42

5.23 (0.68%)

GOOGL

Alphabet Class A

$795.17

3.7 (0.47%)

SNE

Sony

$29.16

0.55 (1.92%)

VIVHY

Vivendi

$18.83

-0.455 (-2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

ATH

Athene Holding

19:33
12/08/16
12/08
19:33
12/08/16
19:33
Syndicate
Athene Holding 27M share IPO priced at $40.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MMM

3M

$175.88

-0.17 (-0.10%)

19:29
12/08/16
12/08
19:29
12/08/16
19:29
Hot Stocks
3M to sell identity management business to Gemalto for $850M »

3M announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SMI

SMIC

$5.99

-0.54 (-8.27%)

19:24
12/08/16
12/08
19:24
12/08/16
19:24
Hot Stocks
SMIC announces 10-for-1 reverse stock split »

Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTR

Ventas

$62.61

0.41 (0.66%)

19:10
12/08/16
12/08
19:10
12/08/16
19:10
Hot Stocks
Ventas raises quarterly dividend 6% to 77.5c per share »

Ventas said that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$57.29

0.01 (0.02%)

19:08
12/08/16
12/08
19:08
12/08/16
19:08
Periodicals
Wells Fargo chairman appointed to sales investigation committee, Reuters says »

Wells Fargo chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

WFC

Wells Fargo

$57.29

0.01 (0.02%)

19:03
12/08/16
12/08
19:03
12/08/16
19:03
Periodicals
Former Wells Fargo managers file suit over fake accounts, Bloomberg reports »

Three former Wells Fargo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

EIX

Edison International

$69.44

-0.17 (-0.24%)

18:42
12/08/16
12/08
18:42
12/08/16
18:42
Hot Stocks
Edison International raises annual dividend 13% to $2.17 per share »

Edison International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLM

PolyMet Mining

$0.87

0.0001 (0.01%)

18:24
12/08/16
12/08
18:24
12/08/16
18:24
Earnings
Breaking Earnings news story on PolyMet Mining »

PolyMet Mining reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTCH

Match Group

$18.38

0.18 (0.99%)

18:24
12/08/16
12/08
18:24
12/08/16
18:24
Hot Stocks
Match Group launches 'Swipe Ventures,' says Tinder CEO to step down »

Match Group's Tinder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$289.54

4.24 (1.49%)

18:18
12/08/16
12/08
18:18
12/08/16
18:18
Hot Stocks
Biogen to present aducanumab Phase 1b data at CTAD meeting »

Biogen announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

HIVE

Aerohive

$5.41

0.18 (3.44%)

18:17
12/08/16
12/08
18:17
12/08/16
18:17
Hot Stocks
Discovery Group reports 9.1% stake in Aerohive Networks, sends letter to board »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLK

EnLink Midstream Partners

$17.45

0.2 (1.16%)

, ENLC

EnLink Midstream

$18.20

0.1 (0.55%)

18:05
12/08/16
12/08
18:05
12/08/16
18:05
Periodicals
Outrigger Energy nears sale to midstream services provider, Forbes says »

Private-equity backed…

ENLK

EnLink Midstream Partners

$17.45

0.2 (1.16%)

ENLC

EnLink Midstream

$18.20

0.1 (0.55%)

TRGP

Targa Resources

$54.20

0.38 (0.71%)

ETP

Energy Transfer Partners

$35.13

0.55 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$78.65

0.96 (1.24%)

18:02
12/08/16
12/08
18:02
12/08/16
18:02
Hot Stocks
Post Holdings settles egg antitrust class action claims »

Post Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENZN

Enzon

$0.44

-0.0027 (-0.62%)

17:54
12/08/16
12/08
17:54
12/08/16
17:54
Hot Stocks
Icahn says enters standstill pact with Enzon »

In an amended filing on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LDOS

Leidos

$52.27

0.15 (0.29%)

17:53
12/08/16
12/08
17:53
12/08/16
17:53
Hot Stocks
Leidos awarded $350M government contract »

Leidos, Reston, Virginia,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDC

Dominion Diamond

$10.27

0.21 (2.09%)

17:50
12/08/16
12/08
17:50
12/08/16
17:50
Hot Stocks
Dominion Diamond sees FY17 production at Ekati diamond mine 4.5M carats »

Sees FY17 Ekati diamond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

FNSR

Finisar

$34.13

1.89 (5.86%)

, AVGO

Broadcom

$170.71

2.16 (1.28%)

17:49
12/08/16
12/08
17:49
12/08/16
17:49
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

FNSR

Finisar

$34.13

1.89 (5.86%)

AVGO

Broadcom

$170.71

2.16 (1.28%)

GLPG

Galapagos NV

$58.95

0.71 (1.22%)

XTLY

Xactly

$14.35

0.35 (2.50%)

RH

Restoration Hardware

$38.99

1.05 (2.77%)

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

NCS

NCI Building

$17.85

0.6 (3.48%)

FRED

Fred's

$10.84

0.15 (1.40%)

USAC

USA Compression

$18.01

-0.14 (-0.77%)

FRO

Frontline

$7.71

0.37 (5.04%)

WSM

Williams-Sonoma

$56.90

0.61 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 09

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Dec

ESRX

Express Scripts

$70.75

-5.1 (-6.72%)

, ANTM

Anthem

$146.61

1.41 (0.97%)

17:48
12/08/16
12/08
17:48
12/08/16
17:48
Hot Stocks
Citron's Andrew Left: 'By no means' calling Express Scripts a fraud or zero »

Speaking in a CNBC…

ESRX

Express Scripts

$70.75

-5.1 (-6.72%)

ANTM

Anthem

$146.61

1.41 (0.97%)

CVS

CVS Health

$78.11

-2.42 (-3.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

DDC

Dominion Diamond

$10.27

0.21 (2.09%)

17:45
12/08/16
12/08
17:45
12/08/16
17:45
Earnings
Dominion Diamond reports Q3 EPS 34c with items, consensus (32c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.